PL2552242T3 - Mieszanka mleczna dla niemowląt o niskiej zawartości białka i zwiększonej ilości aminokwasów egzogennych - Google Patents

Mieszanka mleczna dla niemowląt o niskiej zawartości białka i zwiększonej ilości aminokwasów egzogennych

Info

Publication number
PL2552242T3
PL2552242T3 PL11712054T PL11712054T PL2552242T3 PL 2552242 T3 PL2552242 T3 PL 2552242T3 PL 11712054 T PL11712054 T PL 11712054T PL 11712054 T PL11712054 T PL 11712054T PL 2552242 T3 PL2552242 T3 PL 2552242T3
Authority
PL
Poland
Prior art keywords
amino acids
essential amino
infant formula
low protein
protein infant
Prior art date
Application number
PL11712054T
Other languages
English (en)
Other versions
PL2552242T5 (pl
Inventor
Goudoever Johannes Bernard Van
Der Beek Eline Marleen Van
Marieke Abrahamse-Berkeveld
Günther Boehm
Original Assignee
Nutricia Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=43216285&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL2552242(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Nutricia Nv filed Critical Nutricia Nv
Publication of PL2552242T3 publication Critical patent/PL2552242T3/pl
Publication of PL2552242T5 publication Critical patent/PL2552242T5/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; PREPARATION THEREOF
    • A23C11/00—Milk substitutes, e.g. coffee whitener compositions
    • A23C11/02—Milk substitutes, e.g. coffee whitener compositions containing at least one non-milk component as source of fats or proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/19—Dairy proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/332—Promoters of weight control and weight loss
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00—Food ingredients
    • A23V2250/02—Acid
    • A23V2250/06—Amino acid
    • A23V2250/0626—Isoleucine
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00—Food ingredients
    • A23V2250/02—Acid
    • A23V2250/06—Amino acid
    • A23V2250/0628—Leucine
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00—Food ingredients
    • A23V2250/02—Acid
    • A23V2250/06—Amino acid
    • A23V2250/0654—Valine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/02—Peptides of undefined number of amino acids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pediatric Medicine (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Dairy Products (AREA)
PL11712054T 2010-03-26 2011-03-25 Mieszanka mleczna dla niemowląt o niskiej zawartości białka i zwiększonej ilości aminokwasów egzogennych PL2552242T5 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
PCT/NL2010/050156 WO2011119023A1 (en) 2010-03-26 2010-03-26 Low protein infant formula with increased essential amino acids
EP11712054.3A EP2552242B2 (en) 2010-03-26 2011-03-25 Low protein infant formula with increased essential amino acids
PCT/NL2011/050207 WO2011119033A1 (en) 2010-03-26 2011-03-25 Low protein infant formula with increased essential amino acids

Publications (2)

Publication Number Publication Date
PL2552242T3 true PL2552242T3 (pl) 2016-03-31
PL2552242T5 PL2552242T5 (pl) 2021-11-08

Family

ID=43216285

Family Applications (1)

Application Number Title Priority Date Filing Date
PL11712054T PL2552242T5 (pl) 2010-03-26 2011-03-25 Mieszanka mleczna dla niemowląt o niskiej zawartości białka i zwiększonej ilości aminokwasów egzogennych

Country Status (13)

Country Link
US (3) US8987196B2 (pl)
EP (2) EP2984942B1 (pl)
CN (2) CN102892309B (pl)
BR (1) BR112012024102B1 (pl)
DK (2) DK2552242T4 (pl)
ES (1) ES2555257T5 (pl)
HU (1) HUE025633T2 (pl)
MY (2) MY177379A (pl)
PH (1) PH12012501842B1 (pl)
PL (1) PL2552242T5 (pl)
PT (1) PT2552242E (pl)
RU (1) RU2559432C2 (pl)
WO (2) WO2011119023A1 (pl)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5875701B2 (ja) * 2011-12-14 2016-03-02 ネステク ソシエテ アノニム 子供の年齢又は発達段階に適切な食物を予測するための方法
RU2634407C2 (ru) 2012-03-26 2017-10-26 Эксселла Хелт Инк. Фрагменты пищевых белков и способы их применения
EP2831100A4 (en) * 2012-03-26 2016-02-10 Pronutria Inc NUTRIENT PROTEINS AND METHOD
EP2831098A4 (en) 2012-03-26 2016-12-07 Axcella Health Inc LOADED NUTRIENT PROTEINS AND METHODS
US9700071B2 (en) 2012-03-26 2017-07-11 Axcella Health Inc. Nutritive fragments, proteins and methods
EP2922414B1 (en) * 2012-11-23 2019-11-13 N.V. Nutricia Formulas comprising optimised amino acid profiles
WO2015046183A1 (ja) 2013-09-24 2015-04-02 味の素株式会社 糖アミノ酸およびその用途
RU2016110800A (ru) 2013-09-25 2017-10-30 Пронутриа Биосайенсис, Инк. Составы и композиции для поддержания и увеличения мышечной массы, силы и результативности, и способы их производства и использования
RU2638323C1 (ru) 2013-11-29 2017-12-13 Нестек С.А. Применение питательных композиций с низким количеством белка
MX381155B (es) 2013-11-29 2025-03-12 Soc Des Produits Nestle S A Star Composiciones nutritivas adaptadas a la edad con un contenido de proteína variable.
HK1231398A1 (zh) 2014-04-08 2017-12-22 Abbott Laboratories 使用人乳寡糖增强对病原体的粘膜先天免疫反应和/或检测的方法
WO2015154259A1 (en) * 2014-04-09 2015-10-15 Nestle (China) Ltd. Gender specific synthetic nutritional compositions and nutritional systems comprising them
EP3145333B1 (en) * 2014-05-19 2020-11-04 N.V. Nutricia Infant formula with optimised amino acid profiles
PL3145334T3 (pl) * 2014-05-19 2020-06-01 N.V. Nutricia Formulacje dojelitowe dla przedwcześnie urodzonych niemowląt zawierające zoptymalizowane poziomy przyjmowania fenyloalaniny
CN104012659B (zh) * 2014-06-26 2016-04-20 中恩（天津）营养科技有限公司 一种用于苯丙酮尿症儿童的配方粉及其制备方法
US10835544B2 (en) 2014-12-08 2020-11-17 Glycom A/S Synthetic composition for regulating satiety
EP3229812A4 (en) * 2014-12-08 2018-10-03 Glycom A/S Synthetic composition for treating metabolic disorders
US10881674B2 (en) 2014-12-08 2021-01-05 Glycom A/S Synthetic composition for treating metabolic disorders
US10987368B2 (en) 2014-12-08 2021-04-27 Glycom A/S Synthetic composition for preventing or treating CVD
US10500179B2 (en) 2015-10-02 2019-12-10 N. V. Nutricia Glycine for use in tolerance induction in allergic patients
WO2017069613A1 (en) * 2015-10-23 2017-04-27 N.V. Nutricia Method for improving recognition and/or working memory in hyperphenylalanimenia and phenylketonuria patients
WO2017215721A1 (en) * 2016-06-15 2017-12-21 Glycom A/S Synthetic compositions comprising human milk oligosaccharides for use γν the prevention and treatment of disorders
WO2018042255A2 (en) * 2016-08-31 2018-03-08 Lange Martin R Nutritional compositions and methods of using same
US20200315235A1 (en) * 2016-10-05 2020-10-08 N. V. Nutricia Normalization of the Intestinal Microbiota Composition in Infants or Toddlers Fed with an Amino Acid-Based Nutritional Composition
JOP20190146A1 (ar) 2016-12-19 2019-06-18 Axcella Health Inc تركيبات حمض أميني وطرق لمعالجة أمراض الكبد
DE102017200007A1 (de) 2017-01-02 2018-07-05 Schott Ag Spritze mit unterschiedlichen Materialien
MX2020001765A (es) 2017-08-14 2020-07-29 Axcella Health Inc Composiciones de aminoacidos para el tratamiento de enfermedad hepatica.
GB2566971B (en) * 2017-09-28 2020-12-02 Mjn Us Holdings Llc Infant formula having decreased protein content
WO2019139754A2 (en) * 2017-12-19 2019-07-18 The Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Compositions and methods for fetal growth
CN112839643A (zh) 2018-06-20 2021-05-25 胺细拉健康公司 用于治疗肌肉中脂肪浸润的组合物及方法
CN109527093A (zh) * 2018-12-27 2019-03-29 安徽康博特保健食品有限公司 一种婴幼儿营养包特殊膳食产品及其制备方法
RU2721605C1 (ru) * 2019-11-11 2020-05-21 Общество с ограниченной ответственностью "Ай Кью Витаминная студия" Фармацевтическая композиция для парентерального капельного введения
EP4297587A4 (en) * 2021-02-24 2025-01-08 Milk Care Co., Inc. Infant formulas containing human breast milk proteins
CN113092652B (zh) * 2021-03-19 2022-09-30 浙江工商大学 一种用于评估个体过敏程度的试剂盒
WO2025088004A1 (en) 2023-10-27 2025-05-01 Société des Produits Nestlé S.A. Paediatric formulations for phenylketonuria and tyrosinaemia and specific free amino acid mixture
CN118415243B (zh) * 2024-07-05 2024-11-05 内蒙古伊利实业集团股份有限公司 可改善芳香族氨基酸生物利用度的营养组合物及其应用

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3697287A (en) * 1969-01-28 1972-10-10 Morton Norwich Products Inc Amino acid food composition
US4252822A (en) * 1979-12-26 1981-02-24 Children's Hospital Medical Center Method for treating phenylketonuria
FI904074A7 (fi) * 1989-08-28 1991-03-01 Milupa Ag Optimoidun aminohappokoostumuksen omaavat proteiini-, peptidi- ja aminohapposeokset sekä niiden käyttö keskosten ja rintalasten ravinnon sekä äidinmaidon lisäaineiden valmistamiseksi
US5132113A (en) * 1990-10-26 1992-07-21 Maurizio Luca Nutritional composition containing essential amino acids
DE4042115C2 (de) 1990-12-28 1993-11-25 Milupa Ag Phenylalaninfreie Säuglings- und Kleinkindernahrungsgrundlage und Verfahren zu ihrer Herstellung
DE69331528T2 (de) 1992-12-23 2002-10-31 Abbott Laboratories, Abbott Park Medizinische nahrungsmittel für die ernährungsergänzung bei metabolischen erkrankungen von säuglingen/kleinkindern
US5719133A (en) 1994-09-21 1998-02-17 Novartis Nutrition Ag Adolescent dietary composition
EP1062873A1 (en) * 1999-12-13 2000-12-27 N.V. Nutricia Improved infant formula, protein hydrolysate for use in such an infant formula, and method for producing such a hydrolysate
US6511696B2 (en) 2000-12-13 2003-01-28 Novartis Nutrition Ag Infant formula with free amino acids and nucleotides
US6503530B1 (en) * 2001-11-01 2003-01-07 Chunghee Kimberly Kang Method of preventing development of severe metabolic derangement in inborn errors of metabolism
US7651716B2 (en) * 2001-12-21 2010-01-26 Wyeth Llc Methods for reducing adverse effects of feeding formula to infants
DE10221403A1 (de) * 2002-05-14 2003-12-04 Kyberg Pharma Vertriebs Gmbh & Diätetische und pharmazeutische Zusammensetzungen, ihre Herstellung und ihre Verwendung
DE112006002215A5 (de) * 2005-08-23 2008-07-03 Leweling, Hans, Dr. Proteinzusammensetzung zur Behandlung von Proteinmangelzuständen
EP1774973A1 (en) * 2005-10-12 2007-04-18 Nutricia N.V. Leucine rich composition
WO2008054192A1 (en) 2006-11-02 2008-05-08 N.V. Nutricia Use of nutritional compositions for preventing disorders
WO2008027991A2 (en) * 2006-08-29 2008-03-06 Martek Biosciences Corporation USE OF DPA(n-6) OILS IN INFANT FORMULA
CA2679300C (en) * 2007-02-28 2015-10-06 Meiji Dairies Corporation Amino acid composition
US20100317562A1 (en) * 2007-03-23 2010-12-16 Lynn Paolella Dietary Compositions

Also Published As

Publication number Publication date
HUE025633T2 (en) 2016-04-28
MY177379A (en) 2020-09-14
PL2552242T5 (pl) 2021-11-08
US20130079276A1 (en) 2013-03-28
EP2552242B2 (en) 2021-09-01
CN107821606A (zh) 2018-03-23
WO2011119023A1 (en) 2011-09-29
RU2012145528A (ru) 2014-05-20
DK2552242T4 (da) 2021-11-01
ES2555257T3 (es) 2015-12-30
EP2552242A1 (en) 2013-02-06
US9492498B2 (en) 2016-11-15
EP2984942A1 (en) 2016-02-17
DK2984942T3 (da) 2020-06-15
US20170181460A1 (en) 2017-06-29
BR112012024102A2 (pt) 2015-09-01
EP2552242B1 (en) 2015-09-09
PH12012501842B1 (en) 2018-02-07
CN102892309A (zh) 2013-01-23
DK2552242T3 (en) 2015-12-21
EP2984942B1 (en) 2020-04-22
US8987196B2 (en) 2015-03-24
MY160552A (en) 2017-03-15
CN102892309B (zh) 2016-01-27
CN107821606B (zh) 2021-09-14
ES2555257T5 (es) 2022-02-25
RU2559432C2 (ru) 2015-08-10
WO2011119033A1 (en) 2011-09-29
BR112012024102B1 (pt) 2020-01-28
US10136668B2 (en) 2018-11-27
PH12012501842A1 (en) 2013-01-07
US20150352178A1 (en) 2015-12-10
PT2552242E (pt) 2016-01-08

Similar Documents

Publication Publication Date Title
PH12012501842A1 (en) Low protein infant formula with increased essential amino acids
IL260045B (en) Polypeptide structures and their uses
IL231824A0 (en) Formulations of etanercept stabilized with amino acids
IL224441B (en) Antibodies with modified isoelectric points
IL222961A0 (en) Novel dna-dinding proteins and uses thereof
EP2555797A4 (en) TNF-ALPHA-BINDING PROTEINS
EP2649189A4 (en) TNF-ALPHA-BINDING PROTEINS
IL232158A0 (en) N-terminally modified amino acid derivatives that can be used to form microspheres that surround a drug
PL3590949T3 (pl) Kwasy rybonukleinowe zawierające n1-metylo-pseudouracyle i ich zastosowania
IL230918A0 (en) Modified proteins and peptides
ZA201207331B (en) Concentrated protein formulations and uses thereof
SG10201802316VA (en) Protein purification
IL235425B (en) History of lysine-glutamic acid di-peptide
EP2565200A4 (en) ANTIFREEZE PROTEIN
SG10201606218WA (en) Purified Proteins
IL206528A0 (en) Soy protein concentrate
ZA201305485B (en) Plant protein hydrolysates
IL240134A0 (en) new proteins
IL231664A0 (en) Novel peptide histories as antibiotics
EP2751074A4 (en) 5-SULPHISOPHTHALIC ACID SALTS AND PROCESS FOR THE PREPARATION THEREOF
GB201009520D0 (en) Amino acid derivatives
GB201014094D0 (en) Amino acid derivatives
HK1196089A (en) Protein formulations containing amino acids
GB201113089D0 (en) Protein hydrolysates
GB0906872D0 (en) Amino acid derivatives